| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/09/2003 | EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 07/09/2003 | CN1429273A Protection against environmental toxicity through manipulation of processing of messenger RNA precursors |
| 07/09/2003 | CN1429226A Piperazine and piperidine compounds |
| 07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
| 07/09/2003 | CN1429221A 2-phenylpyran-4-one derivatives |
| 07/09/2003 | CN1429215A 三唑衍生物 Triazole derivatives |
| 07/09/2003 | CN1429210A Substituted thioacetamides |
| 07/09/2003 | CN1429209A Disulfide derivatives useful for treating allergic diseases |
| 07/09/2003 | CN1429206A 磺酰胺衍生物 Sulfonamide derivatives |
| 07/09/2003 | CN1429205A 磺酰胺衍生物 Sulfonamide derivatives |
| 07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
| 07/09/2003 | CN1429118A Aromatase inhibitors and monoclonal anti-HER2 anti-bodies as antitumors agents |
| 07/09/2003 | CN1429111A Methods for inhibiting proliferation and inducing apoptosis in cancer cells |
| 07/09/2003 | CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 07/09/2003 | CN1429109A Compositions comprising blockers of L-DOPA renal cell transfer for treatment of Parkinson's disease |
| 07/09/2003 | CN1429108A 磷酸盐运输抑制剂 Phosphate transport inhibitor |
| 07/09/2003 | CN1429106A Methods for inhibiting angiogenesis and tumor growth |
| 07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
| 07/09/2003 | CN1429101A Stabilized aqueous suspensions for parenteral administration |
| 07/09/2003 | CN1429073A A gene therapy system and method using alpha-MSH and its derivatives |
| 07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
| 07/09/2003 | CN1113895C Growth hormone secretagogues |
| 07/09/2003 | CN1113888C Tetraphosphonate bicyclic trisanhydrides |
| 07/09/2003 | CN1113881C 8-substituted-1,3,8-triaza-spiro [4.5] decan-4-on derivatives |
| 07/09/2003 | CN1113877C Effective synthetic method for furau sulfonic acid amide compound for synthesizing new IL-1 inhibitor |
| 07/09/2003 | CN1113874C Benzocycloalkylazolethione derivatives |
| 07/09/2003 | CN1113867C Amino anthracyclinone derivatives and their use in treatment of amyloidosis |
| 07/09/2003 | CN1113862C Arysulfonylamino hydroxamic acid derivs. |
| 07/09/2003 | CN1113657C Slow-releasing concentrated fish oil tablet and its preparation method |
| 07/09/2003 | CN1113652C Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and treating human malignant tumour |
| 07/09/2003 | CN1113648C Use of tetrahydro-beta-carboline derivative as antimetastatic carcinoma preparation |
| 07/08/2003 | US6590105 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits |
| 07/08/2003 | US6590089 Isolated cDNA encoding a protein of given amino acid sequence; use in diagnosis and treatment of cell proliferative disorders (cancer) and autoimmune disorders |
| 07/08/2003 | US6590079 Vitazin antibody; treating angiogenesis or restenosis |
| 07/08/2003 | US6590077 Polypeptide, of given sequence, which stimulates increased growth or altered cell morphology in cells; use in diagnosis, treatment, and prevention of autoimmune/inflammatory, cell proliferative, and vesicle trafficking disorders |
| 07/08/2003 | US6589991 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/08/2003 | US6589977 Bisindolylpyrrole derivatives represented by general formula (I) which are useful in inhibiting cell death and expected as being useful as preventives and remedies for the progress of various diseases in the progress and worsening of which cell |
| 07/08/2003 | US6589972 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects |
| 07/08/2003 | US6589964 Method for enhancing mutant enzyme activities in lysosomal storage disorders |
| 07/08/2003 | US6589959 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt |
| 07/08/2003 | US6589952 Imidazo[1,2-a]pyrazines for the treatment of neurological disorders |
| 07/08/2003 | US6589951 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 07/08/2003 | US6589950 Treatment of inflammatory or obstructive airways disease for respiratory system disorders |
| 07/08/2003 | US6589948 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 07/08/2003 | US6589946 Bile salt conjugates |
| 07/08/2003 | US6589945 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
| 07/08/2003 | US6589944 A method of cleaving glycation endproducts or cross-linked proteins in an organism in need thereof, wherein said method comprises administering an effective amount of a compound or pharmaceutically acceptable salt thereof to said organism for |
| 07/08/2003 | US6589782 VEGF (Vascular Endothelial Growth Factor); adenovirus vector; Use in treating cardiovascular disorders, enhancing the neovascularization of diseased blood vessels and enhancing drug delivery via improved vascular permeability |
| 07/08/2003 | US6589764 IL-18 receptor fusion proteins |
| 07/08/2003 | US6589747 Detecting modulators of proteins associated with ionic mobility; obtain cell, incubate with amyloid protein, monitor cells for reduced ionic mobility |
| 07/08/2003 | US6589725 Adding candidate drug to a cell comprising a recombinant nucleic acid encoding the protein and determining its effect on cell proliferation and viability; drug screening |
| 07/08/2003 | US6589528 Contacting monocytes with monoclonal antibody that binds to fusion regulatory Protein-1 exposed on surface of monocytes |
| 07/08/2003 | US6589525 Method and device for preparing a dental implant by immersion in a culture of mesenchymal cells |
| 07/08/2003 | US6589523 Agent for gene therapy of dilated cardiomyopathy |
| 07/08/2003 | US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 07/08/2003 | CA2280395C New hydroxamic acid derivatives, their preparation process and the pharmaceutical compositions which contain them |
| 07/08/2003 | CA2264372C New benzocyclobutane compounds, their method of preparation, and pharmaceutical compositions containing them |
| 07/08/2003 | CA2153549C New benzothiadiazine derivative, process for preparing the same and pharmaceutical compositions containing said derivative |
| 07/08/2003 | CA2140428C Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 07/08/2003 | CA2133646C Stem cell proliferation factor |
| 07/07/2003 | CA2415591A1 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators |
| 07/03/2003 | WO2003054541A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | WO2003054216A2 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | WO2003054194A2 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 07/03/2003 | WO2003054156A2 Novel g proein-coupled receptor, gave7 |
| 07/03/2003 | WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | WO2003054077A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 07/03/2003 | WO2003054018A2 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003054009A2 Apoptotically active peptides |
| 07/03/2003 | WO2003054002A1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours |
| 07/03/2003 | WO2003054000A1 Template-fixed peptidomimeticsas inhibitors of serine proteases |
| 07/03/2003 | WO2003053999A2 Selective arylguanidine peptides as urokinase inhibitors |
| 07/03/2003 | WO2003053997A2 Methods of increasing endogenous erythropoietin (epo) |
| 07/03/2003 | WO2003053979A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/03/2003 | WO2003053977A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 07/03/2003 | WO2003053975A1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity |
| 07/03/2003 | WO2003053971A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | WO2003053969A1 Imidazoquinoline derivatives |
| 07/03/2003 | WO2003053967A1 Aroyl pyridinones |
| 07/03/2003 | WO2003053966A2 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 07/03/2003 | WO2003053961A1 Benzothiazoles |
| 07/03/2003 | WO2003053960A2 Quinline derivates and their use as mek inhibitors |
| 07/03/2003 | WO2003053957A1 Benzhydryl derivatives |
| 07/03/2003 | WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 07/03/2003 | WO2003053948A1 Isochroman compounds for treatment of cns disorders |
| 07/03/2003 | WO2003053947A1 Benzothia(dia)zine derivatives and their use as ampa modulators |
| 07/03/2003 | WO2003053946A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 07/03/2003 | WO2003053945A2 Urea derivatives and their use as vanilloid receptor antagonists |
| 07/03/2003 | WO2003053944A1 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 07/03/2003 | WO2003053939A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 07/03/2003 | WO2003053933A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 07/03/2003 | WO2003053928A1 Serotonine reuptake inhibitor |
| 07/03/2003 | WO2003053927A1 Piperazine derivative |
| 07/03/2003 | WO2003053926A1 Novel phenylalanine derivative |
| 07/03/2003 | WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | WO2003053923A2 Pyrrolidine derivatives as prostaglandin modulators |
| 07/03/2003 | WO2003053921A2 Mutant proteinase inhibitors and uses thereof |
| 07/03/2003 | WO2003053920A1 Crystals of bicalutamide and process for their production |